The bioactive coating tethers restorative proteins to implanted tissues and fosters new growth, animal studies suggest.

The steroid’s exceptional performance in early results from the RECOVERY clinical trial in the United Kingdom is a rational outcome of the drug’s anti-inflammatory effects, experts say.

The drug Vyondys 53 has met a surrogate endpoint of protein production, but there’s no clear proof it has a clinical benefit.

A study in mice suggests serotonin release underlies the drug’s prosocial effects while dopamine mediates the rewarding properties that drive its potential for abuse.

The school will not return donations from the family that made its riches on opioids, but the university will start a $3 million endowment for addiction prevention and treatment.

Roughly a quarter of 38 viral samples from people treated with Xofluza had mutations in their genomes that made the pathogens less susceptible to the drug.

The Henderson State University academics face charges of manufacturing methamphetamine and using drug paraphernalia.

The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.

The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.